Your browser doesn't support javascript.
loading
Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication.
Krishnan, Shuba; Nordqvist, Hampus; Ambikan, Anoop T; Gupta, Soham; Sperk, Maike; Svensson-Akusjärvi, Sara; Mikaeloff, Flora; Benfeitas, Rui; Saccon, Elisa; Ponnan, Sivasankaran Munusamy; Rodriguez, Jimmy Esneider; Nikouyan, Negin; Odeh, Amani; Ahlén, Gustaf; Asghar, Muhammad; Sällberg, Matti; Vesterbacka, Jan; Nowak, Piotr; Végvári, Ákos; Sönnerborg, Anders; Treutiger, Carl Johan; Neogi, Ujjwal.
Afiliación
  • Krishnan S; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Nordqvist H; Södersjukhuset (The South General Hospital), Stockholm, Sweden.
  • Ambikan AT; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Gupta S; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Sperk M; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Svensson-Akusjärvi S; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Mikaeloff F; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Benfeitas R; National Bioinformatics Infrastructure Sweden (NBIS), Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden.
  • Saccon E; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Ponnan SM; Centre for Infectious Disease Research, Indian Institute of Science (IISc), Bangalore, Karnataka, India.
  • Rodriguez JE; Division of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Nikouyan N; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Odeh A; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Ahlén G; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Asghar M; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Sällberg M; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden.
  • Vesterbacka J; Department of Medicine Huddinge, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
  • Nowak P; Department of Medicine Huddinge, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden; The Laboratory for Molecular Infection Medicine Sweden MIMS, Umeå University, Umea, Sweden.
  • Végvári Á; Division of Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  • Sönnerborg A; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Treutiger CJ; Södersjukhuset (The South General Hospital), Stockholm, Sweden; Department of Medicine Huddinge, Division of Infectious Diseases, Karolinska Institutet, Stockholm, Sweden.
  • Neogi U; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, ANA Futura, Campus Flemingsberg, Stockholm, Sweden; Manipal Institute of Virology (MIV), Manipal Academy of Higher Education, Manipal, Karnataka, India. Electronic address: ujjwal.neogi@ki.se.
Mol Cell Proteomics ; 20: 100159, 2021.
Article en En | MEDLINE | ID: mdl-34619366

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Sanguíneas / SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Sanguíneas / SARS-CoV-2 / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article